miR-144-3p Promotes Adipogenesis Through Releasing C/EBPα From Klf3 and CtBP2

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
• miR-144-3p is a known biomarker for type 2 diabetes, but its role in adipogenesis was unclear.
• Adipogenesis, the process of fat cell formation, is crucial in metabolic health and disease.

Purpose of the Study:

• To investigate the role of miR-144-3p in regulating adipogenesis.
• To identify the molecular targets and mechanisms through which miR-144-3p influences fat cell development.
• To assess the potential of miR-144-3p as a therapeutic target for obesity and metabolic syndrome.

Main Methods:

• Quantitative real-time PCR to measure miRNA and gene expression.
• Cell culture experiments using 3T3-L1 pre-adipocytes for overexpression studies.
• Luciferase reporter assays to confirm direct targeting of genes.
• In vivo studies involving tail-vein injection of miR-144-3p agomir in mice.

Main Results:

• miR-144-3p expression was upregulated in obese mice and during 3T3-L1 cell differentiation.
• Overexpression of miR-144-3p inhibited pre-adipocyte proliferation but promoted lipid accumulation and adipogenesis.
• miR-144-3p directly targeted and suppressed the expression of Klf3 and CtBP2, key regulators of adipogenesis.
• miR-144-3p enhanced adipogenesis in vivo, leading to increased lipid accumulation in mice.

Conclusions:

• miR-144-3p facilitates adipogenesis both in vitro and in vivo.
• The mechanism involves the suppression of Klf3 and CtBP2, leading to increased C/EBPα activity.
• miR-144-3p represents a potential therapeutic target for treating obesity and related metabolic disorders.